Artwork

Content provided by Numinus Network. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by Numinus Network or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://ppacc.player.fm/legal.
Player FM - Podcast App
Go offline with the Player FM app!

FDA rejects MAPS/Lykos MDMA therapy for PTSD

43:15
 
Share
 

Manage episode 435191642 series 2943386
Content provided by Numinus Network. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by Numinus Network or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://ppacc.player.fm/legal.

Send us a text

On Aug 9th the FDA rejected the new drug application by Lykos (formerly MAPS PBC) for MDMA-assisted therapy for PTSD. This is disappointing news for those of us who were excited about the promising study results and eager to add MDMA-assisted therapy to the menu of treatment options for those suffering with PTSD. We discuss what appears to have influenced the FDA’s decision, the possible path forward for Lykos, how this ruling affects other companies trying to bring different psychedelic medicines to market, and much more.

Learn more about our podcast at https://numinusnetwork.com/learn/podcast/
Learn more about psychedelic therapy training opportunities at https://numinusnetwork.com/training/
Learn more about our clinical trials at https://www.numinusnetwork.com/research
Learn more about Numinus at https://numinusnetwork.com/
Email us at [email protected]
Follow us on Instagram:
https://www.instagram.com/drstevethayer/
https://www.instagram.com/innerspacedoctor/
https://www.instagram.com/numinushealth/

  continue reading

211 episodes

Artwork
iconShare
 
Manage episode 435191642 series 2943386
Content provided by Numinus Network. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by Numinus Network or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://ppacc.player.fm/legal.

Send us a text

On Aug 9th the FDA rejected the new drug application by Lykos (formerly MAPS PBC) for MDMA-assisted therapy for PTSD. This is disappointing news for those of us who were excited about the promising study results and eager to add MDMA-assisted therapy to the menu of treatment options for those suffering with PTSD. We discuss what appears to have influenced the FDA’s decision, the possible path forward for Lykos, how this ruling affects other companies trying to bring different psychedelic medicines to market, and much more.

Learn more about our podcast at https://numinusnetwork.com/learn/podcast/
Learn more about psychedelic therapy training opportunities at https://numinusnetwork.com/training/
Learn more about our clinical trials at https://www.numinusnetwork.com/research
Learn more about Numinus at https://numinusnetwork.com/
Email us at [email protected]
Follow us on Instagram:
https://www.instagram.com/drstevethayer/
https://www.instagram.com/innerspacedoctor/
https://www.instagram.com/numinushealth/

  continue reading

211 episodes

All episodes

×
 
Loading …

Welcome to Player FM!

Player FM is scanning the web for high-quality podcasts for you to enjoy right now. It's the best podcast app and works on Android, iPhone, and the web. Signup to sync subscriptions across devices.

 

Quick Reference Guide

Copyright 2025 | Privacy Policy | Terms of Service | | Copyright
Listen to this show while you explore
Play